The studies of Szulman (1960, 1962a, b, 1964) and Hakomori (1981) have already established a link between ontogenesis, oncogenesis and A, B and H antigen expression. Immunohistochemical studies by a number of groups have demonstrated that the development of carcinomas within a number of organs including lung (Davidson & Ni, 1969) , cervix (Davidson et al., 1969) and prostate (Gupta et al., 1973) have been associated with the loss of A and B isoantigens. We have simultaneously reported work that suggests that the deletion of ABO(H) blood group isoantigens (BGIs) that has been previously described within prostatic epithelium following malignant transformation is largely limited to a deletion of the A and B isoantigens (Vowden et al., 1985) . This disagrees with the previously stated findings of Gupta et al. 1973 , who found a loss of all these antigens. Recent reports by Strauchen et al., (1980) , and by Shull et al. (1981) have suggested that BGIs are lost from malignant breast epithelium. Both these groups have, however, relied upon the specific red cell adherence test and have used similar reagents to those employed by Gupta et al. (1973) some histologically benign lesions supports a possible link between fibrocystic disease and mammary carcinoma (Strauchen et al., 1980 (Voak et al., 1982; Lowe et al., 1983; Finan et al., 1983 (Finan et al., 1982a, b) and has been outlined in our earlier paper. Mounted slides were viewed under an Olympus CH microscope and photographed onto KB14 film (ASA 20) . The controls included in this study were identical to those we documented in our report on BGI expression with the prostate (Vowden et al., 1986) .
Results
Normal breast tissue, whether obtained from a pathological or non-pathological source, consistently displayed BGIs. Duct epithelium was found to express the expected antigens in all 66 specimens examined. In contrast in the majority of normal lobules BGIs were only weakly expressed and in most only isolated acini displayed staining. There was, however, considerable variation in the intensity of staining seen between specimens and also a marked variation in staining seen between individual acini within any one specimen. Figure la shows the pattern of staining observed in an area of normal breast tissue taken from a breast containing an invasive scirrhous carcinoma. In all cases erythrocytes and vascular endothelium were found to stain for the expected blood group, those from group A and B subjects also staining for both the H and Y isoantigens.
In specimens from areas of benign breast disease (both fibrocystic and fibroadenomatous) BGI expression was found to be more varied. BGIs were detected in 50% of specimens (7 of 14, see Table I ). Antigen positive specimens showed no obvious histological difference from antigen negative ones. It was of interest that the loss of BGIs from these specimens was generally associated with the loss of all BGIs as opposed to the loss of A and B isoantigens which was the most common finding in malignant breast epithelium. Within cysts the whole epithelium was either antigen positive or negative, the staining of cyst debris following the pattern established by the cyst epithelium. This variation may be related to secretor status but this was not examined in this study. Figures la-c These represent sections from a mastectomy specimen from a blood group A subject. In (a) an area of normal breast epithelium is shown stained with A15/3D3. Szulman (1962) found the pattern of BGI expression within the breast interesting, for even in normal breast tissue the epithelial elements showed extremely irregular BGI expression. The picture of antigen expression not only varies from lobule to lobule but also within lobules where ductules and acini containing BGIs were found adjacent to antigen deficient structures. Non-secretors were found to express little or no blood group antigen. A similar pattern of BGI expression has been reported by Strauchen et al. (1980) . This group reported that duct epithelium was strongly positive while normal lobules only weakly expressed A and B antigens, the pattern of antigen expression being the same whether the material was obtained from pathological or non-pathological biopsies. Davidsohn and Stejskal (1972) using similar material and an identical technique to that employed by Strauchen (1962) found normal breast tissue to be BGI deficient. The results obtained in the present study are in broad agreement with those of Szulman (1962) and Strauchen et al. (1980) . We are unable to comment on the role of secretor status on antigen expression, but it may be that secretor status is responsible for some of the variation in antigen expression which we have seen.
The majority of studies have detected BGIs in benign breast lesions (Szulman, 1962; Tellem et al., 1963; Shull et al., 1981) , Strauchen has however reported a reduction in BGIs in cysts, duct hyperplasia, sclerosing adenitis and duct papillomatosis. In the present study BGIs have been found to be reduced and occasionally absent from areas of fibrocystic disease and fibroadenomata.
Of the earlier studies two have failed to identify BGIs in any breast malignancy including in situ carcinomas (Strauchen et al., 1980; Shull et al., 1981 (Vowden et al., 1986) Kim & Isaacs (1975) . Springer et al. (1975 Springer et al. ( , 1979 (Alroy et al., 1978; Wolk & Bishop, 1983) . In both these studies blood group antigen negative transitional cell carcinomas of the bladder were found to have reacquired these antigens following radiotherapy. These changes may simply reflect the heterogeneity of the tumour population. It has been suggested that these changes may indicate 'redifferentiation' of the tumour cells following radiotherapy. Contradictory evidence has been produced by Richie and Yap (1981) . They report no changes in blood group antigen status following radiotherapy. The findings in the present study would tend to support this as in the 6 metastatic lymph nodes examined from post-radiotherapy patients the antigen status paralleled that seen in the nonradiotherapy nodes. There was certainly no reacquisition of either A or B BGIs in the three group A or the group B derived nodes.
Results reported here and in our concurrent studies on the prostate (Vowden et al., 1986) have only served to emphasize the marked cell to cell variation in BGI expression that occurs. This may represent changes in antigen expression by cells at different stages of the cell cycle. Though no evidence has been offered here to support this statement other workers have supported this theory (Hogman, 1960; Pann & Kuhns, 1972) . In fact Hogman has postulated that the capacity to produce BGIs may be lost during cell division. Dabelstein and Fejerskor (1974) have produced data supporting this, documenting the loss of blood group antigens in healing oral epithelium. Changes in the cell membrane glycolipids during cell division have been described (Hakomori, 1981) and may be responsible for the overall change in antigen expression.
To conclude, we have documented the presence of BGIs in normal breast tissue and in the majority of benign breast lesions. In contrast to other studies we have found that although malignant transformation is associated with a loss of both A and B isoantigens the H and Y BGIs are maintained in the bulk of tumours.
